Explanatory Note
This Amendment No. 1 (“Amendment No. 1”) to Schedule 13D amends and supplements the statement on Schedule 13D originally filed with the United States Securities and Exchange Commission (“SEC”) on July 16, 2021 (as amended the “Schedule 13D”), relating to the common stock, par value $0.01 per share (the “Common Shares”), of Scholastic Corporation, a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 557 Broadway, New York, NY 10012. The Issuer’s Common Shares are traded on the Nasdaq Stock Exchange under the stock symbol “SCHL”.
The Items below amend the information disclosed under the corresponding Items of the Schedule 13D as described below. Except as specifically provided herein, this Amendment No. 1 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used but not defined herein shall have the meanings attributed to them in the Schedule 13D.
Item 4. Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended and supplemented as follows:
On January 12, 2024 the Estate converted 445,452 shares of Class A Stock, $0.01 par value, into an equal number of Common Shares. In connection with the administration of the Estate, including in connection with generating liquidity to meet certain estate obligations, Ms. Lucchese, solely in her capacity as a preliminary executor of the Estate, expects to explore selling a portion or all of the Common Shares held by the Estate.
Other than as described in this Item 4, or otherwise in this Schedule 13D, Ms. Lucchese (individually and in her capacity as a preliminary executor of the Estate) currently has no plans or proposals which relate to or would result in any of the matters set forth in subparagraphs (a)-(j) of Item 4 of Form Schedule 13D. In the foregoing capacities, Ms. Lucchese reserves the right, in light of her future evaluation of the Issuer’s financial condition, business, operations and prospects, the market price of the Common Shares, conditions in the securities markets generally, general economic and industry conditions and other relevant factors, to change her plans and intentions at any time, as she deems appropriate.
As a senior executive officer of the Issuer and Chair of the Board of Directors of the Issuer, Ms. Lucchese participates in deliberations of the Issuer’s senior management and Board of Directors in the normal course of the Issuer’s business that could involve any of the matters set forth in subparagraphs (a)-(j) of the instructions to Item 4 from time to time, and, in keeping with her fiduciary duty as an officer and director, may make proposals or recommendations to the Issuer’s board of directors that could involve such matters from time to time.
In addition, as a member of the Issuer’s senior management, Ms. Lucchese participates in Issuer compensatory plans, including plans pursuant to which awards of equity securities are made (including to Ms. Lucchese), in the ordinary course of business, generally on an annual basis.
Item 5. Interest in Securities of the Issuer.
Items 5 (a)-(c) and (e) of the Schedule 13D are hereby amended and restated as follows:
(a) Incorporated herein by reference is the information from Items 11 and 13 of the cover page of the applicable Reporting Person. The beneficial ownership of both of the Reporting Persons together is 1,623,752 Common Shares, or 5.5% of the Common Shares issued and outstanding. Calculations of the percentage of the Shares beneficially owned assumes that there are 28,044,770 Common Shares outstanding as of December 31, 2023 as provided by the Issuer, plus 828,100 Common Shares which reflects the conversion by the Estate and certain other Class A shareholders of Class A Shares into an equal number of Common Shares, plus 445,452 Class A Shares which continue to be held by the Estate that are immediately convertible into Common Shares, plus, in the case of Ms. Lucchese, currently exercisable options to purchase 144,833 Common Shares held by Ms. Lucchese individually.
4